ASPI — ASP Isotopes Income Statement
0.000.00%
- $158.39m
- $159.48m
- $0.43m
Annual income statement for ASP Isotopes, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 0 | 0 | 0.433 |
Cost of Revenue | |||
Gross Profit | — | — | 0.139 |
Selling / General / Administrative Expenses | |||
Research And Development | |||
Total Operating Expenses | 2.61 | 5.1 | 16.5 |
Operating Profit | -2.61 | -5.1 | -16 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -2.61 | -4.95 | -16.3 |
Provision for Income Taxes | |||
Net Income After Taxes | -2.61 | -4.95 | -16.3 |
Minority Interest | |||
Net Income Before Extraordinary Items | |||
Net Income | -2.61 | -4.95 | -16.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -2.61 | -4.95 | -16.3 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -0.083 | -0.185 | -0.493 |
Dividends per Share |